These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 6363048

  • 1. Reduction of C-peptide secretion in noninsulin-dependent diabetic patients with long duration of insulin treatment.
    Hsieh SD, Akanuma Y, Kawazu S, Mashiko S, Kanazawa Y, Iwamoto Y, Kikuchi M, Kosaka K.
    Endocrinol Jpn; 1983 Jun; 30(3):373-80. PubMed ID: 6363048
    [Abstract] [Full Text] [Related]

  • 2. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
    Hsieh SD, Kanazawa Y, Akanuma Y.
    Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
    [Abstract] [Full Text] [Related]

  • 3. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
    Hsieh SD, Akanuma Y, Takaku F.
    Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
    [Abstract] [Full Text] [Related]

  • 4. Instability of fasting blood glucose values in noninsulin-dependent diabetic patients with long-term insulin treatment.
    Hsieh SD, Akanuma Y.
    Metabolism; 1985 Apr; 34(4):371-6. PubMed ID: 3884966
    [Abstract] [Full Text] [Related]

  • 5. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY, Haus E, Lakatua DJ, Bogdan C, Petrescu E, Sackett-Lundeen L, Stelea S, Stelea P.
    Endocrinologie; 1984 Apr; 22(1):3-16. PubMed ID: 6369501
    [Abstract] [Full Text] [Related]

  • 6. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H, Matsuyama T, Fujii S, Komatsu R, Nishioeda Y, Omae T.
    Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
    [Abstract] [Full Text] [Related]

  • 7. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD, Iwamoto Y, Matsuda A, Kuzuya T.
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [Abstract] [Full Text] [Related]

  • 8. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y, Kondo K, Hasegawa H, Oiso Y.
    Diabetes Res; 1994 Aug; 25(3):129-37. PubMed ID: 7671552
    [Abstract] [Full Text] [Related]

  • 9. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T, Ohneda A, Nihei J, Kobayashi T.
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [Abstract] [Full Text] [Related]

  • 10. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG, Owusu SK, Schuster DP, Osei K.
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [Abstract] [Full Text] [Related]

  • 11. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
    Wakasaki H, Shono T, Nakao R, Yamamoto S, Minaga T, Fukuda S, Matsumoto R, Ohoshi T, Naka K, Nanjo K.
    Intern Med; 2020 May; 59(18):2229-2235. PubMed ID: 32938850
    [Abstract] [Full Text] [Related]

  • 12. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
    Kudolo GB.
    J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
    [Abstract] [Full Text] [Related]

  • 13. Study of A- and B-cell function in beta-thalassemia major.
    Maioli M, Pacifico A, Frulio T, Longinotti M.
    Acta Diabetol Lat; 1983 Jun; 20(2):143-52. PubMed ID: 6349202
    [Abstract] [Full Text] [Related]

  • 14. Insulin secretory responses in patients with glucose intolerance due to extra-pancreatic causes. Comparison with idiopathic diabetes mellitus.
    Kosaka K, Kuzuya T, Hagura R, Akanuma Y, Kanazawa Y.
    Endocrinol Jpn; 1981 Aug; 28(4):487-98. PubMed ID: 6763894
    [Abstract] [Full Text] [Related]

  • 15. Duration of residual B-cell function in maturity-onset diabetes.
    Cignarelli M, Cospite MR, Stefanelli G, Guastamacchia E, Nardelli G, Giorgino R.
    Acta Diabetol Lat; 1984 Aug; 21(2):161-6. PubMed ID: 6382892
    [Abstract] [Full Text] [Related]

  • 16. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy.
    Grant PJ, Barlow E, Miles DW.
    Diabet Med; 1984 Nov; 1(4):284-6. PubMed ID: 6242818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.